NEPTUNE DIGITAL ASSETS CORP
NPPTF
Intchains Group
ICG
The9 Ltd
NCTY
SATO TECHNOLOGIES CORP
CCPUF
Ebang International
EBON
US Stock MarketDetailed Quotes
ASLN Aslan Pharmaceuticals
- 0.6000
- 0.00000.00%
Trading Jul 18 16:00 ET
1.70MMarket Cap-0.04P/E (TTM)
0.0000High0.0000Low0Volume0.0000Open0.6000Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)2.83MShares16.720052wk High-0.09P/B1.49MFloat Cap0.475052wk Low--Dividend TTM2.49MShs Float417.5600Historical High--Div YieldTTM0.00%Amplitude0.4750Historical Low--Avg Price1Lot Size
Aslan Pharmaceuticals Key Stats
EPS
According to the latest financial report of Aslan Pharmaceuticals, the latest earnings per share (TTM) for the company is -4.00. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Aslan Pharmaceuticals's free cash flow? The latest report shows it as -5.04M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Aslan Pharmaceuticals shows that the company's current ratio is 1.05, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Aslan Pharmaceuticals, the quick ratio is 0.94, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Aslan Pharmaceuticals? The latest ROE figure is -353.77%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Aslan Pharmaceuticals, the total asset return on investment (ROA) is -43.49%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Aslan Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 100.00%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Aslan Pharmaceuticals, the net profit margin is -15.71%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.